Epileptic discharges in acutely ill patients investigated for SARS‐CoV‐2/COVID‐19 and the absence of evidence

摘要

Galanopoulou and coauthors reported that epileptogenic discharges (ED) were frequent in COVID‐19 patients with encephalopathy or possible seizures.1 They found that ED were more prevalent in COVID‐19 patients (9/22, 41%) than in patients whose COVID‐19 test was negative (1/6, 17%; P = .37; Fisher's exact t‐test). They rightly concluded that more information was necessary to test whether COVID‐19 infection increases the risk of epileptiform abnormalities.